Table 3.
Patient demographics and baseline characteristics of the four phenotypes of PCOS
| Phenotype A | Phenotype B | Phenotype C | Phenotype D | |
|---|---|---|---|---|
| Total number of patients (n) | 47 | 6 | 14 | 7 |
| Age (years) | 34.3 (25–49) | 38.9 (36–40) | 32.7 (27–43) | 34.2 (31–38) |
| Body Weight (kg) | 75.5 (46.7–117.0) | 66.9 (54.4–81.6) | 60.2 (51.0–104.0) | 60.5 (47.0–79.4) |
| BMI (kg/m2) | 28.8 (18.7–40.0) | 24.0 (19.2–29.0) | 24.3 (19.2–37.4) | 22.3 (17.8–29.1) |
| Menstrual cycle Duration (days) | 33.5 (16–60) | 27 (23–30) | 28.5 (26–32) | 28.5 (26–33) |
| AMH level (pmol/l) | 55.5 (2.2–131.7) | 7.9 (2.7–11.4) | 30.4 (5.2–82.1) | 26.1 (14.4–33.8) |
| AFC- for both ovaries (n) | 38.7 (1–40) | 13.5 (3–19) | 25 (10–40) | 24 (15–30) |
| Average time interval between hormone analysis (AMH) and start of treatment with follitropin delta (months) | 6.7 | 5.8 | 6 | 7.4 |
| Number of patients prescribed treatments for infertility prior to ovarian stimulation (lifestyle modifications/metformin, etc) (n) | 21 | 3 | 2 | 3 |
| Number of patients on agonist protocols (n) | 0 | 0 | 2 | 0 |
| Number of patients on antagonist protocols (n) | 47 | 6 | 12 | 7 |
| Number of first IVF/ICSI cycles (n) | 31 | 6 | 10 | 4 |
| Number of subsequent IVF/ICSI cycles (n) | 16 | 0 | 4 | 3 |